Venture Capital Deals and Investments
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Venture Capital Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
Sibel Health Closes Series C Extension to $39M Led by Maruho and Samsung Next
Series CVenture Capital

Sibel Health Closes Series C Extension to $39M Led by Maruho and Samsung Next

•October 14, 2025
•Oct 14, 2025
0

Participants

Sibel Health

Sibel Health

company

Maruho Co.,Ltd

Maruho Co.,Ltd

investor

Samsung Next

Samsung Next

investor

Deal Summary

Chicago-based digital health company Sibel Health extended its Series C to $39M in a round led by Maruho Co., Ltd. and Samsung Next. The company will use proceeds to expand operations and advance product development.

0

Comments

Want to join the conversation?

Loading comments...